- Skystar Bio-Pharmaceutical Company (OTC:SKBI): Q3 EPS of $0.57
- Revenue of $18.35M (+14.8% Y/Y).
- Press Release
Skystar Bio reports Q3 profit
Recommended For You
More Trending News
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| SKBI | - | - |
| Skystar Bio-Pharmaceutical Company | ||